Be a part of 6^th International Conference on Addiction Research and Psychiatry

Addiction Neuroscience & Neurobiology: Brain reward circuits, neuroplasticity, dopamine pathways, stress mechanisms, and neural mechanisms of addiction.
Precision Psychiatry & Personalized Addiction Treatment: Biomarker-guided treatment, patient stratification, pharmacogenomics, individualized therapies, and treatment-response prediction.
AI, Machine Learning & Digital Technologies in Addiction Care: AI-assisted diagnosis, predictive analytics, digital therapeutics, mobile interventions, wearable technologies, and virtual care.
Psychedelic-Assisted Therapy & Emerging Pharmacotherapies: Psilocybin, MDMA, ketamine, ibogaine, novel pharmacological targets, mechanisms of action, and clinical-trial developments. Psychedelic-assisted approaches are a particularly active research area in 2026.
Opioid Use Disorder & Next-Generation Treatments: Opioid crisis, medication-assisted treatment, novel therapeutics, overdose prevention, treatment access, and long-term recovery.
Alcohol & Tobacco/Nicotine Addiction Research: Alcohol use disorder, vaping, nicotine dependence, smoking cessation, emerging nicotine products, and evidence-based interventions.
Behavioural Addictions & Compulsive Disorders: Gambling, gaming, social-media addiction, internet use, compulsive behaviours, and emerging digital-age dependencies.
Addiction & Co-Occurring Psychiatric Disorders: Depression, anxiety, PTSD, psychosis, ADHD, personality disorders, suicide risk, and integrated dual-diagnosis treatment.
Biomarkers, Genetics, Epigenetics & Neuroimaging: Genomic and epigenomic mechanisms, fMRI, PET, EEG, molecular biomarkers, and predictors of relapse and treatment response.
Relapse Prevention, Recovery & Long-Term Care: Craving and relapse mechanisms, recovery models, psychosocial interventions, peer support, rehabilitation, and continuing care.
Adolescent Addiction, Prevention & Public Health: Early intervention, youth substance use, family-based prevention, school programs, social determinants, and population-level strategies.
Harm Reduction, Addiction Policy & Global Mental Health: Overdose prevention, harm-reduction strategies, healthcare accessibility, stigma reduction, regulatory frameworks, and international addiction policies.